Burson Cohn & Wolfe on Behalf of Astrazeneca Pharmaceuticals LP
Biopharmaceutical company
Based in DE
🤖
AI Overview
With $330K in lobbying spend across 5 quarterly filings, Burson Cohn & Wolfe on Behalf of Astrazeneca Pharmaceuticals LP is an active lobbying client. They deploy 11 individual lobbyists Their lobbying covers 3 issue areas. Active from 2020 to 2021.
$330K
Total Spend
2
Years Active
1
Firms Hired
11
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $0 |
| 2021 | $330K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Trade, Health Issues
- •COVID-19 vaccine and therapy development
- •Intellectual property issues
- •COVID-19 vaccine development, manufacturing, and distribution
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.